The prognostic value of HER-2/neu overexpression in colorectal cancer: evidence from 16 studies.

scientific article published on 31 July 2014

The prognostic value of HER-2/neu overexpression in colorectal cancer: evidence from 16 studies. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S13277-014-2376-0
P698PubMed publication ID25077923

P2093author name stringYu Yang
Cong-Chao Ma
Sheng-Wen Wu
P2860cites workOver-expression of Her-2 in colorectal cancer tissue, but not in serum, constitutes an independent worse prognostic factorQ86876904
Cancer statistics, 2010Q27860525
Measuring inconsistency in meta-analysesQ27860655
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008Q27860674
Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogeneQ27860693
Cancer statistics, 2013Q27860762
Practical methods for incorporating summary time-to-event data into meta-analysisQ28131754
Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancerQ29547699
ERBB receptors and cancer: the complexity of targeted inhibitorsQ29619520
Is overexpression of HER-2 a predictor of prognosis in colorectal cancer?Q30856729
Colorectal cancer in Guangdong Province of China: a demographic and anatomic surveyQ33688323
Clinicopathological and prognostic significance of HER-2/neu and VEGF expression in colon carcinomasQ33943812
Her-2/neu and breast cancerQ34365892
Prognostic role of CD133 expression in colorectal cancer: a meta-analysisQ34502600
Much ado about nothing: a comparison of the performance of meta-analytical methods with rare events.Q34510811
Prognostic value of CD166 expression in cancers of the digestive system: a systematic review and meta-analysisQ34936453
Adjuvant trastuzumab in HER2-positive breast cancerQ35710898
Amplification of the c-erbB-2 (HER-2/neu) gene in gastric cancer cells. Detection by fluorescence in situ hybridizationQ35763518
c-erbB-2 is not a major factor in the development of colorectal cancerQ36644043
The ErbB signalling pathway: protein expression and prognostic value in epithelial ovarian cancerQ36785983
The expression of multiple proteins as prognostic factors in colorectal cancer: cathepsin D, p53, COX-2, epidermal growth factor receptor, C-erbB-2, and Ki-67Q37564008
Promoter CpG island methylation markers in colorectal cancer: the road aheadQ37997086
HER-2/neu overexpression is an independent prognostic factor in colorectal cancer.Q40291966
Prognostic significance of p53 and c-erbB-2 immunohistochemical evaluation in colorectal adenocarcinomaQ40981286
Targeted HER2 treatment in advanced gastric cancerQ43148962
ErbB family immunohistochemical expression in colorectal cancer patients with higher risk of recurrence after radical surgery.Q47950050
Clinical role of HER-2/neu expression in colorectal cancer.Q51046708
Frequency of HER-2 positivity in rectal cancer and prognosis.Q51283402
Prognostic significance of c-erbB-2 and vascular endothelial growth factor in colorectal liver metastases.Q51789617
Clinico-Pathological and Prognostic Significance of p53, Bcl-2 and Her-2/neu Protein Markers in Colorectal Cancer Using Tissue Microarray.Q53317073
Assessment of staging, prognosis and mortality of colorectal cancer by tumor markers: receptor erbB-2 and cadherins.Q53648066
Expression of EGFR, Her2 predict lymph node metastasis (LNM)-associated metastasis in colorectal cancer.Q54280357
Serum levels of HER-2 neu (C-erbB-2) correlate with overexpression of p185neu in human ovarian cancerQ72221452
The prognostic value of invariant chain (Ii) and Her-2/neu expression in curatively resected colorectal cancerQ74325369
Immunohistochemical study of c-erbB-2 protein in colorectal cancer and the correlation with patient survivalQ77432075
P433issue11
P921main subjectcolorectal cancerQ188874
overexpressionQ61643320
P304page(s)10799-10804
P577publication date2014-07-31
P1433published inTumor BiologyQ15757842
P1476titleThe prognostic value of HER-2/neu overexpression in colorectal cancer: evidence from 16 studies.
P478volume35

Reverse relations

cites work (P2860)
Q40212670Association of HER2 codon 655 polymorphism with ovarian cancer
Q26801167Correlation of human epidermal growth factor receptor protein expression and colorectal cancer
Q35651481Expression of COX-2 and HER-2 in colorectal cancer and their correlation
Q36020920HER-2 and HER-3 expression in liver metastases of patients with colorectal cancer.
Q28078111HER2 aberrations and heterogeneity in cancers of the digestive system: Implications for pathologists and gastroenterologists
Q35029025HER2 expression in gastric and oesophageal cancer: a meta-analytic review

Search more.